Eli Lilly sues Cipla for infringing testosterone patents

01-11-2016

Eli Lilly sues Cipla for infringing testosterone patents

Photo: Courtesy of Eli Lilly

Eli Lilly has filed a complaint against India-based drug company Cipla for allegedly infringing its patents covering Axiron (testosterone topical).


Eli Lilly, Cipla, patent, testosterone, Axiron, ANDA, FDA

LSIPR